Literature DB >> 13547042

The cocarcinogenic activity of cigarette tobacco tar.

A GELLHORN.   

Abstract

Entities:  

Keywords:  BENZOPYRENES/injurious effects; NEOPLASMS/experimental; SMOKING/injurious effects

Mesh:

Substances:

Year:  1958        PMID: 13547042

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Phenolic fraction of tobacco smoke inhibits BPDE-induced apoptosis response and potentiates cell transformation: role of attenuation of p53 response.

Authors:  Jagat J Mukherjee; Subodh Kumar; Ronald Gocinski; Jacquan Williams
Journal:  Chem Res Toxicol       Date:  2011-04-20       Impact factor: 3.739

2.  Phenolic fraction of tobacco smoke condensate potentiates benzo[a]pyerene diol epoxide-induced cell transformation: role of protein kinase C.

Authors:  Jagat J Mukherjee; Subodh Kumar
Journal:  Mutat Res       Date:  2009-12-16       Impact factor: 2.433

3.  DNA synthesis inhibition in response to benzo[a]pyrene dihydrodiol epoxide is associated with attenuation of p(34)cdc2: Role of p53.

Authors:  Jagat J Mukherjee; Subodh Kumar
Journal:  Mutat Res       Date:  2013-05-18       Impact factor: 2.433

4.  Inactivation of adenovirus and simian virus 40 tumorigenicity in hamsters by vaccine processing methods.

Authors:  G T Truffelli; E A Timm; W B Beardmore; I W McLean
Journal:  Appl Microbiol       Date:  1967-05

5.  The tar fraction of cigarette smoke does not promote arteriosclerotic plaque development.

Authors:  A Penn; K Keller; C Snyder; A Nadas; L C Chen
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

6.  Incomplete carcinogens in cigarette smoke condensate: tumour-promotion by a phenolic fraction.

Authors:  F J ROE; M H SALAMAN; J COHEN
Journal:  Br J Cancer       Date:  1959-12       Impact factor: 7.640

7.  Tumour promotion by the neutral fraction of cigarette smoke.

Authors:  G R CLEMO; E W MILLER
Journal:  Br J Cancer       Date:  1960-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.